medical guideline
首页
中医/中西医结合指南
肿瘤学指南
泌尿外科指南
关于我们
郑重声明
联系我们
首页
肿瘤学指南
检索结果
人体系统
运动
骨肿瘤
软组织肿瘤
骨与软组织肿瘤
硬纤维瘤
骶尾部畸胎瘤
神经
中枢神经系统肿瘤
嗜铬细胞瘤和副神经节瘤
副神经节瘤
胶质细胞瘤
前庭神经鞘瘤
星形胶质细胞瘤和少突胶质细胞瘤
弥漫性胶质瘤
神经纤维瘤
神经细胞瘤
神经内分泌肿瘤
内分泌
甲状腺肿瘤
垂体肿瘤
肾上腺肿瘤
甲状旁腺肿瘤
胸腺肿瘤
神经内分泌肿瘤
循环
心脏肿瘤
淋巴瘤
骨髓瘤
白血病
血液肿瘤
血管瘤
呼吸
肺癌
鼻咽癌
喉部肿瘤
下咽癌
鼻腔和副鼻窦癌
呼吸道肿瘤
鼻颅咽管瘤
淋巴管肌瘤
消化
胰腺肿瘤
口腔癌
肛门癌
口咽癌
胆囊癌
胆管肿瘤
直肠癌
结肠癌
胃癌
小肠癌
肝癌
大肠肿瘤
唾液腺癌
阑尾肿瘤
食管肿瘤
肝肿瘤
壶腹肿瘤
肝胆癌
结直肠肿瘤
食管胃肿瘤
胃肠道肿瘤
消化道肿瘤
泌尿
膀胱肿瘤
肾癌
脐尿管癌
尿路上皮癌
肾血管平滑肌脂肪瘤
泌尿生殖肿瘤
生殖
女性
子宫肿瘤
卵巢肿瘤
乳腺肿瘤
阴道肿瘤
输卵管癌
外阴癌
妊娠滋养细胞肿瘤
妇科肿瘤
男性
前列腺肿瘤
性索间质瘤
睾丸肿瘤
阴茎癌
男性乳腺肿瘤
泌尿生殖肿瘤
其他
症状管理
治疗方案
诊断/检测/评估方法
预防和筛查
COVID-19大流行癌症患者相关指导建议
皮肤肿瘤
黑色素瘤
头颈部肿瘤
康复营养
生育能力
体力活动
心理健康
腹膜肿瘤
实体瘤
胸部肿瘤
长期监测
Cowden综合征
转诊
遗传性癌症综合征
癌症患者其他类问题管理
寡转移性疾病
基因测序
易感基因变异的分类
外科肿瘤
罕见癌症
不明原因癌症
纤维瘤
腹部肿瘤
老年肿瘤
儿童/青少年肿瘤
人类微生物组与癌变
检索结果
按关键字
按标题
按关键词
按摘要
按作者
按期刊
按发表年份
共搜索到
117条
与
test
有关的结果
Expert Consensus on PD-L1 Expression Testing in Non-small-cell Lung Cancer in China
2020年 发布于
Zhonghua Zhong Liu Za Zhi
42卷 第7期
所属人体系统:
呼吸
|
肺癌
Tumor Pathology Committee of Chinese Anti-Cancer Association
Expert Committee on Pathology of Chinese Society of Clinical Oncology
Expert Committee on Non-Small Cell Lung Cancer of Chinese Society of Clinical Oncology
Expert Consensus
Non-small-cell Lung Cancer
Programmed Death Ligand 1
Testing.
指南简介
原文链接
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Desmoplastic Small Round Cell Tumor, Breast, and Gastrointestinal Stromal Tumors
2020年 发布于
Cancer
126卷 第11期
所属人体系统:
其他
|
腹膜肿瘤
Chicago Consensus Working Group
Breast Neoplasms
Consensus
Desmoplastic Small Round Cell Tumor
Gastroin
test
inal Stromal Tumor
Neoplasm Metastasis
Peritoneal Neoplasms.
指南简介
原文链接
Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline
2020年 发布于
American Society of Clinical Oncology
卷 第期
所属人体系统:
生殖
|
卵巢肿瘤
American Society of Clinical Oncology
Ovarian Cancer
genetic Testing
tumor Testing
epithelial
expert Consensus
指南简介
原文链接
Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline Summary
2020年 发布于
JCO Oncology Practice
16卷 第8期
所属人体系统:
生殖
|
卵巢肿瘤
American Society of Clinical Oncology
Epithelial Ovarian Cancer
Germline
Somatic Tumor Testing
Guideline
指南简介
原文链接
European Consensus-based Interdisciplinary Guideline for Melanoma. Part 1: Diagnostics - Update 2019
2020年 发布于
Eur J Cancer
126卷 第期
所属人体系统:
其他
|
黑色素瘤
European Dermatology Forum
European Association of Dermato-Oncology
European Organization of Research and Treatment of Cancer
AJCC Classification
Confocal Reflectance Microscopy
Cutaneous Melanoma
Dermatoscopy
Follow-up Examinations
Imaging Diagnostics
Mutation Testing
Primary Diagnosis
Sequential Digital Dermatoscopy
Total Body Photography.
指南简介
原文链接
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update
2020年 发布于
American Society of Clinical Oncology
卷 第期
所属人体系统:
生殖
|
乳腺肿瘤
American Society of Clinical Oncology
Breast Cancer
Estrogen
Progesterone Receptor
Testing
指南简介
原文链接
Consensus on Pathological Diagnosis of Gastrointestinal Adenoma and Benign Epithelial Polyps
2020年 发布于
Zhonghua Bing Li Xue Za Zhi
49卷 第1期
所属人体系统:
消化
|
胃肠道肿瘤
Group of Digistive Diseases of Chinese Society of Pathology
Gastroin
test
inal Adenoma
Pathological Diagnosis
Consensus
指南简介
原文链接
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Desmoplastic Small Round Cell Tumor, Breast, and Gastrointestinal Stromal Tumors
2020年 发布于
Cancer
126卷 第11期
所属人体系统:
消化
|
胃肠道肿瘤
Chicago Consensus Working Group
Breast Neoplasms
Consensus
Desmoplastic Small Round Cell Tumor
Gastroin
test
inal Stromal Tumor
Neoplasm Metastasis
Peritoneal Neoplasms.
指南简介
原文链接
MASCC/ISOO Clinical Practice Guidelines for the Management of Mucositis Secondary to Cancer Therapy
2020年 发布于
Cancer
126卷 第19期
所属人体系统:
其他
|
症状管理
Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology
Multinational Association of Supportive Care in Cancer and International Society for Oral Oncology (MASCC/ISOO)
Cancer
Gastroin
test
inal
Guidelines
Mucositis
Oral.
指南简介
原文链接
French CcAFU Guidelines - Update 2020-2022: Testicular Germ Cell Tumors
2020年 发布于
Progres En Urologie
30卷 第12S期
所属人体系统:
生殖
|
睾丸肿瘤
Cancer Committee of the Association Française D'Urologie
BEP
Cancer Du Testicule
Chimiothérapie
Curage Ganglionnaire Rétro Péritonéal
Orchidectomie
Orchiectomy
PEB Chemotherapy
Radiotherapy
Radiothérapie
Retroperitoneal Lymphadenectomy
Testicular Neoplasms.
指南简介
原文链接
Report from the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: IV: Current and Future Utilization of Molecular-Genetic Tests for Testicular Germ Cell Tumors
2020年 发布于
Am J Surg Pathol
44卷 第7期
所属人体系统:
生殖
|
睾丸肿瘤
International Society of Urological Pathology
Testicular Germ Cell Tumors
Molecular-genetic Tests
Guideline
指南简介
原文链接
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Desmoplastic Small Round Cell Tumor, Breast, and Gastrointestinal Stromal Tumors
2020年 发布于
Cancer
126卷 第11期
所属人体系统:
生殖
|
乳腺肿瘤
Chicago Consensus Working Group
Breast Neoplasms
Consensus
Desmoplastic Small Round Cell Tumor
Gastroin
test
inal Stromal Tumor
Neoplasm Metastasis
Peritoneal Neoplasms.
指南简介
原文链接
Molecular Testing for Advanced Non-small Cell Lung Cancer in Malaysia: Consensus Statement from the College of Pathologists, Academy of Medicine Malaysia, the Malaysian Thoracic Society, and the Malaysian Ontological Society
2019年 发布于
Lung Cancer
136卷 第期
所属人体系统:
呼吸
|
肺癌
College of Pathologists
Academy of Medicine Malaysia
the Malaysian Thoracic Society
and the Malaysian Oncological Society
Guidelines
Molecular Testing
Non-small Cell Lung Cancer
Targeted Therapy
Tissue Biopsy
指南简介
原文链接
Biomarkers in Non-Small Cell Lung Cancers: Indian Consensus Guidelines for Molecular Testing
2019年 发布于
Advances in Therapy
36卷 第4期
所属人体系统:
呼吸
|
肺癌
无
Biomarkers
Molecular Testing
Non-small Cell Lung Cancers
Consensus
Guideline
指南简介
原文链接
Australian Consensus Statement for Best Practice ROS1 Testing in Advanced Non-small Cell Lung Cancer
2019年 发布于
Pathology
51卷 第7期
所属人体系统:
呼吸
|
肺癌
无
Non-small Cell Lung Cancer
ROS1
Biomarker Testing
Consensus
指南简介
原文链接
Hereditary Gastrointestinal Cancers: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up†
2019年 发布于
Annals of oncology : official journal of the European Society for Medical Oncology
30卷 第10期
所属人体系统:
消化
|
胃肠道肿瘤
European Society for Medical Oncology
Gastroin
test
inal Cancer
Diagnosis
Treatment
Follow-up
Guideline
指南简介
原文链接
Diagnostic Value of Imaging (ultrasonography, Doppler, CT, MR, PET-CT) for the Diagnosis of a Suspicious Ovarian Mass and Staging of Ovarian, Tubal Or Primary Peritoneal Cancer: Article Drafted from the French Guidelines in Oncology Entitled `Initial Man
2019年 发布于
Gynecol Obstet Fertil Senol
47卷 第2期
所属人体系统:
生殖
|
输卵管癌
FRANCOGYN (Groupe Français De Recherche En Chirurgie Oncologique Et Gynécologique)
Au CNGOF (Collège National Des Gynécologues Obstétriciens Français)
À La SFOG (Société Française D’oncologie Gynécologique Et Au Groupe GINECO-ARCAGY (Groupe D’investigateurs Nationaux Pour L’étude Des Cancers Ovariens Et Du Sein – Association De Recherche Sur Les Cancers Dont Gynécologiques) Et Sont Labellisées Par L’INCa (Institut National Du Cancer).
Transvaginal Ultrasound Is the First-line Examination Allowing Characterizing 80 to 90% of Adnexal Masses (LP1). If Performed by an Expert
a Subjective Analysis Is Optimal. If Performed by a Non-expert
Combining the Use of Simple Rules with Subjective Analysis Can Achieve the Diagnostic Performance of an Expert (LP1). Whichever the Chosen Model (subjective Analysis by an Expert Or Combination of the Simple Rules with a Subjective Analysis by a Non-expert)
a Second-line Examination Will Have to Be Proposed in the Complex Or Indeterminate Cases (about 20% of the Masses) (grade A). the Best-performing Second-line Test for Characterization Is Pelvic MRI (LP1). If Read by an Expert
a Pathological Hypothesis Can Or Should Be Suggested (grade D). in Case of Non-expert Reading
the Use of the ADNEXMR Score Allows a Reliable Assessment of the Positive Predictive Value of Malignancy to Guide the Patient Towards the Best Management (gradeC). for Preoperative Assessment and Evaluation of Resectability of Ovarian
Fallopian Tube Or Primary Peritoneal Cancer
It Is Recommended to Perform a Chest Abdomen and Pelvis CT with Contrast Agent Injection (LP2
Grade B). in the Event of a Contraindication to the Injection of Iodinated Contrast Agent (severe Renal Insufficiency
GFR <30mL/min)
an Abdomen and Pelvis MRI Completed with a Non-injected Chest CT May Be Proposed (LP3
Grade C). by Analogy
the Same Examinations Are Recommended to Evaluate the Disease after Neo-adjuvant Chemotherapy (LP3
Recommendation Grade C). Further Studies Will Be Required to Determine Whether PET-CT Provides Better Lymph Node Assessment Before Retroperitoneal and Pelvic Lymphadenectomy. PET-CT May Be Used to Eliminate Lymph Node Involvement in the Absence of Suspicious Lymph Nodes on Morphological Examination (LP3
Grade C). the Report Should Specify the Localizations Leading to a Risk of Incomplete Cytoreductive Surgery and Lesions Outside the Field Explored During Surgery.
指南简介
原文链接
Neoplastic Cell Percentage Estimation in Tissue Samples for Molecular Oncology: Recommendations from a Modified Delphi Study
2019年 发布于
Histopathology
75卷 第3期
所属人体系统:
其他
|
诊断/检测/评估方法
无
Molecular Biomarker Testing
Neoplastic Cell Percentage
Recommendations
指南简介
原文链接
Report from the 20th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; 28-29 September 2018
2019年 发布于
Curr Oncol
26卷 第6期
所属人体系统:
消化
|
结直肠肿瘤
无
Colorectal Cancer
Adjuvant Radiation Therapy
Biomarkers
Cytoreductive Surgery
Hipec
Local Excision
Molecular Tests
Rectal Cancer
Sidedness
Surgery
Surveillance
Total Neoadjuvant Treatment
指南简介
原文链接
Diagnostic Value of Imaging (ultrasonography, Doppler, CT, MR, PET-CT) for the Diagnosis of a Suspicious Ovarian Mass and Staging of Ovarian, Tubal Or Primary Peritoneal Cancer: Article Drafted from the French Guidelines in Oncology Entitled `Initial Man
2019年 发布于
Gynecol Obstet Fertil Senol
47卷 第2期
所属人体系统:
生殖
|
卵巢肿瘤
FRANCOGYN (Groupe Français De Recherche En Chirurgie Oncologique Et Gynécologique)
Au CNGOF (Collège National Des Gynécologues Obstétriciens Français)
À La SFOG (Société Française D’oncologie Gynécologique Et Au Groupe GINECO-ARCAGY (Groupe D’investigateurs Nationaux Pour L’étude Des Cancers Ovariens Et Du Sein – Association De Recherche Sur Les Cancers Dont Gynécologiques) Et Sont Labellisées Par L’INCa (Institut National Du Cancer).
Transvaginal Ultrasound Is the First-line Examination Allowing Characterizing 80 to 90% of Adnexal Masses (LP1). If Performed by an Expert
a Subjective Analysis Is Optimal. If Performed by a Non-expert
Combining the Use of Simple Rules with Subjective Analysis Can Achieve the Diagnostic Performance of an Expert (LP1). Whichever the Chosen Model (subjective Analysis by an Expert Or Combination of the Simple Rules with a Subjective Analysis by a Non-expert)
a Second-line Examination Will Have to Be Proposed in the Complex Or Indeterminate Cases (about 20% of the Masses) (grade A). the Best-performing Second-line Test for Characterization Is Pelvic MRI (LP1). If Read by an Expert
a Pathological Hypothesis Can Or Should Be Suggested (grade D). in Case of Non-expert Reading
the Use of the ADNEXMR Score Allows a Reliable Assessment of the Positive Predictive Value of Malignancy to Guide the Patient Towards the Best Management (gradeC). for Preoperative Assessment and Evaluation of Resectability of Ovarian
Fallopian Tube Or Primary Peritoneal Cancer
It Is Recommended to Perform a Chest Abdomen and Pelvis CT with Contrast Agent Injection (LP2
Grade B). in the Event of a Contraindication to the Injection of Iodinated Contrast Agent (severe Renal Insufficiency
GFR <30mL/min)
an Abdomen and Pelvis MRI Completed with a Non-injected Chest CT May Be Proposed (LP3
Grade C). by Analogy
the Same Examinations Are Recommended to Evaluate the Disease after Neo-adjuvant Chemotherapy (LP3
Recommendation Grade C). Further Studies Will Be Required to Determine Whether PET-CT Provides Better Lymph Node Assessment Before Retroperitoneal and Pelvic Lymphadenectomy. PET-CT May Be Used to Eliminate Lymph Node Involvement in the Absence of Suspicious Lymph Nodes on Morphological Examination (LP3
Grade C). the Report Should Specify the Localizations Leading to a Risk of Incomplete Cytoreductive Surgery and Lesions Outside the Field Explored During Surgery.
指南简介
原文链接
首页
上一页
1
2
3
4
5
6
下一页
尾页
共117条,每页显示
20条
50条
100条
跳转至第
页
确定